U.S. pharmaceutical market: growth
Shown is the growth of the U.S. pharmaceutical market by key segments in 2008.
Growth of the U.S. pharmaceutical market by key segments in 2008 (in percent)
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interest
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you U.S. pharmaceutical industry
Contribution to global pharma
5
- Premium Statistic World pharmaceutical market distribution by submarket 2014-2023
- Premium Statistic World pharmaceutical sales 2020-2023 by region
- Basic Statistic Market share of the leading global pharmaceutical markets 2022
- Premium Statistic Top global pharmaceutical markets: growth rate 2022
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
Overview
6
- Premium Statistic U.S. total medicine spending 2002-2022
- Basic Statistic Leading therapy areas for U.S. drug spending 2020
- Premium Statistic U.S. top prescribed drugs based on sales 2022
- Premium Statistic Top pharma products by prescriptions U.S. 2021
- Premium Statistic Pharmaceutical channel distribution by U.S. spending 2017-2019
- Premium Statistic U.S. biopharmaceutical export volume 2002-2022
Companies
6
- Premium Statistic 2024 list of top U.S. biotech and pharmaceutical companies based on revenue
- Premium Statistic Pharmaceutical corporations by U.S. revenue 2022
- Basic Statistic AbbVie's revenue 2010-2023
- Premium Statistic Pfizer's total revenue 2006-2023
- Premium Statistic Bristol-Myers Squibb's revenue 2006-2023
- Premium Statistic Johnson & Johnson's total sales 2005-2023
Research and development
7
- Basic Statistic Research and development expenditure: U.S. pharmaceutical industry 1995-2022
- Premium Statistic U.S. pharma industry R&D spending as a percent of total revenues 1990-2022
- Basic Statistic Pharmaceuticals: cost of drug development in the U.S. since 1975
- Premium Statistic Number of novel drugs approved annually by CDER 2008-2023
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
- Basic Statistic U.S. sales of new brand medicines 2012-2021
- Basic Statistic R&D expenditure per employee in U.S. sectors 2003-2017
Generics
5
- Basic Statistic Spending change on branded and generic medicines in the U.S. 2014-2021
- Premium Statistic U.S. brand and generic prescription drug spending 2017-2021
- Premium Statistic Branded vs. generic U.S. drug prescriptions dispensed 2005-2021
- Premium Statistic Savings through generic drug usage in the U.S. 2008-2022
- Premium Statistic Sales share at risk of pharmaceuticals due to patent expiries U.S. 2022
Public view on pharma
6
- Premium Statistic Share of U.S. people who had a favorable view of pharmaceutical companies 2021
- Premium Statistic U.S. approval of pharma companies' COVID-19 vaccine development handling 2021
- Premium Statistic Share of U.S. adults who approve pharmaceutical companies' drug price handling 2021
- Basic Statistic Share of people who had a favorable view of Pfizer in U.S. 2021
- Basic Statistic Share of people who had a favorable view of Moderna in U.S. 2021
- Premium Statistic Share of people who had a favorable view of J&J in U.S. 2021
Outlook
4
- Premium Statistic World pharmaceutical sales by region forecast 2027
- Premium Statistic Sales at risk of pharmaceuticals due to patent expiries U.S. 2022
- Basic Statistic Leading U.S. pharmaceutical products by revenue 2026
- Basic Statistic U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection
Further related statistics
10
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Sales of Johnson & Johnson 2006-2023 by region
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Revenue of Sinopharm 2011-2022, by category
- Celgene's revenue and net income 2006-2018
- Key figures on established biotech centers worldwide 2012-2016
Further Content: You might find this interesting as well
Statistics
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Sales of Johnson & Johnson 2006-2023 by region
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Revenue of Sinopharm 2011-2022, by category
- Celgene's revenue and net income 2006-2018
- Key figures on established biotech centers worldwide 2012-2016
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interest
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
IMS Health. (October 2, 2008). Growth of the U.S. pharmaceutical market by key segments in 2008 (in percent) [Graph]. In Statista. Retrieved June 18, 2024, from https://www.statista.com/statistics/266533/us-pharmaceutical-market-growth-by-key-segments-in-2008/
IMS Health. "Growth of the U.S. pharmaceutical market by key segments in 2008 (in percent)." Chart. October 2, 2008. Statista. Accessed June 18, 2024. https://www.statista.com/statistics/266533/us-pharmaceutical-market-growth-by-key-segments-in-2008/
IMS Health. (2008). Growth of the U.S. pharmaceutical market by key segments in 2008 (in percent). Statista. Statista Inc.. Accessed: June 18, 2024. https://www.statista.com/statistics/266533/us-pharmaceutical-market-growth-by-key-segments-in-2008/
IMS Health. "Growth of The U.S. Pharmaceutical Market by Key Segments in 2008 (in Percent)." Statista, Statista Inc., 2 Oct 2008, https://www.statista.com/statistics/266533/us-pharmaceutical-market-growth-by-key-segments-in-2008/
IMS Health, Growth of the U.S. pharmaceutical market by key segments in 2008 (in percent) Statista, https://www.statista.com/statistics/266533/us-pharmaceutical-market-growth-by-key-segments-in-2008/ (last visited June 18, 2024)
Growth of the U.S. pharmaceutical market by key segments in 2008 (in percent) [Graph], IMS Health, October 2, 2008. [Online]. Available: https://www.statista.com/statistics/266533/us-pharmaceutical-market-growth-by-key-segments-in-2008/